VTRS

Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
$16.17
-0.06 (-0.37%)
Mkt Cap: 18.83B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield13.3%
Dividend YieldN/A
Market Cap18.83B
Volume6.61M
Recent News
Here's Why Viatris (VTRS) is a Strong Value Stock
zacks.com · 2026-08-18
Viatris Inc. (VTRS) Q2 2026 Earnings Call Transcript
seekingalpha.com · 2026-08-06
Viatris Inc (VTRS) Shares Fall 7.6% -- GF Value Says Still Overvalued
gurufocus.com · 2026-08-06
Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook
benzinga.com · 2026-08-06
VTRS Q2 Earnings Beat, Revenues Rise 5% as Greater China Sales Jump
zacks.com · 2026-08-06
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics
zacks.com · 2026-08-06

Unlock the Full Deep Scan

9 AI agents analyze VTRS across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →